DK0821969T3 - Medicinsk sammensætning omfattende TCF-II - Google Patents

Medicinsk sammensætning omfattende TCF-II

Info

Publication number: DK0821969T3
Authority: DK; Denmark
Prior art keywords: tcf; medical composition; derived; wound healing; particularly effective
Prior art date: 1992-07-16

Application number

DK97100939T

Other languages

English (en)

Inventor

Hiroaki Masunaga

Nobuaki Fujise

Kanji Higashi

Original Assignee

Daiichi Seiyaku Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-16

Filing date

1993-07-16

Publication date

2007-03-26

1992-07-16 Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja

1992-07-16 Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja

1992-08-10 Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja

1993-07-16 Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co

2007-03-26 Application granted granted Critical

2007-03-26 Publication of DK0821969T3 publication Critical patent/DK0821969T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Surgery (AREA)
Zoology (AREA)
Dermatology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

DK97100939T 1992-07-16 1993-07-16 Medicinsk sammensætning omfattende TCF-II DK0821969T3 (da)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
JP21222992A JP3380573B2 (ja)	1992-07-16	1992-07-16	Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP21222792A JP3619526B2 (ja)	1992-07-16	1992-07-16	Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP4234198A JPH0656692A (ja)	1992-08-10	1992-08-10	Ｔｃｆ−ｉｉを有効成分とする創傷治療剤
EP93305602A EP0588477B1 (en)	1992-07-16	1993-07-16	Medicinal composition comprising TCF-II

Publications (1)

Publication Number	Publication Date
DK0821969T3 true DK0821969T3 (da)	2007-03-26

Family

ID=27329338

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK93305602.0T DK0588477T3 (da)	1992-07-16	1993-07-16	Medicinsk præparat omfatende TCF-11
DK97100939T DK0821969T3 (da)	1992-07-16	1993-07-16	Medicinsk sammensætning omfattende TCF-II

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DK93305602.0T DK0588477T3 (da)	1992-07-16	1993-07-16	Medicinsk præparat omfatende TCF-11

Country Status (7)

Country	Link
EP (3)	EP0588477B1 (da)
KR (1)	KR100271087B1 (da)
AT (3)	ATE345809T1 (da)
CA (1)	CA2100720C (da)
DE (3)	DE69314586T2 (da)
DK (2)	DK0588477T3 (da)
ES (2)	ES2276409T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5714461A (en) *	1992-07-16	1998-02-03	Snow Brand Milk Products Co., Ltd.	Medicinal compositions for the improvement of blood coagulation comprising TCF-II
JP3402476B2 (ja) *	1992-08-24	2003-05-06	生化学工業株式会社	リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) *	1993-09-17	2005-08-10	敏一中村	脳神経障害治療剤
JPH08176007A (ja) *	1994-12-27	1996-07-09	Snow Brand Milk Prod Co Ltd	脂質代謝異常治療剤
JP4006058B2 (ja) *	1997-03-11	2007-11-14	第一三共株式会社	多臓器不全予防及び／又は治療剤
ES2274567T3 (es)	1997-03-14	2007-05-16	Daiichi Pharmaceutical Co., Ltd.	Utilizacion de tcf-ii para el tratamiento de la perdida de peso corporal, la anemia y la elevacion de tnf causadas por el cancer.
JP3961064B2 (ja)	1997-03-28	2007-08-15	第一製薬株式会社	腎疾患予防及び／又は治療剤
JPH1129493A (ja) *	1997-07-14	1999-02-02	Snow Brand Milk Prod Co Ltd	放射線障害予防及び／又は治療剤
JPH11269091A (ja) *	1998-03-19	1999-10-05	Snow Brand Milk Prod Co Ltd	敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3904753A (en) *	1970-02-20	1975-09-09	Research Corp	Clinically active bovine growth hormone fraction
JPS58146293A (ja)	1982-02-26	1983-08-31	Mochida Pharmaceut Co Ltd	抗腫瘍性糖蛋白質の製造方法
US4708948A (en)	1984-04-20	1987-11-24	The United States Of America As Represented By The Department Of Health And Human Services	Substantially purified tumor growth inhibitory factor
DE3419184A1 (de)	1984-05-23	1985-11-28	Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart	Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja)	1985-10-28	1987-05-13	Yoshitomi Pharmaceut Ind Ltd	細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) *	1986-07-14	1996-12-18	修治橋本	肝細胞増殖因子
JPS6410998A (en)	1986-12-22	1989-01-13	Green Cross Corp	Tumor cell inhibitory factor
NZ232813A (en) *	1989-03-10	1992-08-26	Snow Brand Milk Products Co Ltd	Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) *	1989-09-07	1991-07-30	Institute Of Moelcular Biology, Inc.	Wound healing composition of IL-1 and PDGF or IGF-1
DE69133492T2 (de) *	1990-06-11	2006-08-10	Nakamura, Toshikazu	Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
KR0153009B1 (ko)	1990-07-13	1998-10-15	카츄아 쇼노	티씨에프-ii의 아미노산 서열을 암호하는 dna를 함유한 플라스미드 형질전환세포 및 이것을 사용하여 생리 활성물질을 생산하는 방법

1993
- 1993-07-16 DE DE69314586T patent/DE69314586T2/de not_active Expired - Fee Related
- 1993-07-16 ES ES97100939T patent/ES2276409T3/es not_active Expired - Lifetime
- 1993-07-16 EP EP93305602A patent/EP0588477B1/en not_active Expired - Lifetime
- 1993-07-16 DK DK93305602.0T patent/DK0588477T3/da active
- 1993-07-16 DE DE69334087T patent/DE69334087T2/de not_active Expired - Fee Related
- 1993-07-16 CA CA002100720A patent/CA2100720C/en not_active Expired - Fee Related
- 1993-07-16 DK DK97100939T patent/DK0821969T3/da active
- 1993-07-16 AT AT97100939T patent/ATE345809T1/de not_active IP Right Cessation
- 1993-07-16 EP EP06076444A patent/EP1719522B1/en not_active Expired - Lifetime
- 1993-07-16 AT AT93305602T patent/ATE159171T1/de not_active IP Right Cessation
- 1993-07-16 EP EP97100939A patent/EP0821969B1/en not_active Expired - Lifetime
- 1993-07-16 DE DE69334281T patent/DE69334281D1/de not_active Expired - Fee Related
- 1993-07-16 KR KR1019930013391A patent/KR100271087B1/ko not_active IP Right Cessation
- 1993-07-16 AT AT06076444T patent/ATE428438T1/de not_active IP Right Cessation
- 1993-07-16 ES ES93305602T patent/ES2110057T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE69334087D1 (de)	2007-01-04
KR100271087B1 (en)	2000-11-01
DK0588477T3 (da)	1998-03-30
ES2276409T3 (es)	2007-06-16
EP0821969B1 (en)	2006-11-22
CA2100720C (en)	2003-03-11
ATE345809T1 (de)	2006-12-15
DE69334087T2 (de)	2007-07-05
EP0588477A2 (en)	1994-03-23
EP0821969A3 (en)	2000-12-13
EP0588477B1 (en)	1997-10-15
DE69334281D1 (de)	2009-05-28
ES2110057T3 (es)	1998-02-01
EP1719522A1 (en)	2006-11-08
ATE159171T1 (de)	1997-11-15
EP1719522B1 (en)	2009-04-15
KR940005286A (ko)	1994-03-21
AU673835B2 (en)	1996-11-28
ATE428438T1 (de)	2009-05-15
CA2100720A1 (en)	1994-01-17
EP0588477A3 (en)	1994-05-25
AU4194593A (en)	1994-01-20
EP0821969A2 (en)	1998-02-04
DE69314586T2 (de)	1998-02-19
DE69314586D1 (de)	1997-11-20

Publication	Publication Date	Title
NO910340L (no)	1991-07-31	Topiske preparater for behandling av menneskenegler.
NO20004282D0 (no)	2000-08-25	Matriksproteinpreparater for sÕrheling
MX9708800A (es)	1998-02-28	Compuestos biciclicos aromaticos.
DE69814394D1 (de)	2003-06-12	Verwendung von levobupivacain
GR3035762T3 (en)	2001-07-31	Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses
DE68913739D1 (de)	1994-04-14	Kosmetische und hautbehandlungs-zusammensetzungen.
BR9813318A (pt)	2000-08-22	Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
MX9708803A (es)	1998-02-28	Compuestos biaromaticos de propinilo o dienilo.
DE60018409D1 (de)	2005-04-07	Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DK0821969T3 (da)	2007-03-26	Medicinsk sammensætning omfattende TCF-II
ATE174798T1 (de)	1999-01-15	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
GR3032224T3 (en)	2000-04-27	Therapeutic agent for threatened abortion.
DE69621786D1 (de)	2002-07-18	Aminotetralinderivat zur behandlung von herzkreislauferkrankung
NO995692D0 (no)	1999-11-19	Nye BPC-peptidsalter med organbeskyttende aktivitet, metoden for deres fremstilling og deres anvendelse
DE68905076D1 (de)	1993-04-08	Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
TR199901385T2 (xx)	1999-11-22	Piperidin t�revleri.
DE69330809D1 (de)	2001-10-31	Therapeutisches Agens für Neutropenie
DE69719190D1 (de)	2003-03-27	Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
ZA979135B (en)	1998-06-24	New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
KR930703003A (ko)	1993-11-29	피부질환치료용 제약 조성물
ATE102478T1 (de)	1994-03-15	Kosmetische und hautbehandlungszusammensetzungen.
IT224936Z2 (it)	1996-07-31	Presidio chirurgico radiotrasparente per il trattamento di patologie e traumi ortopedici.